多种管控和干预手段促进辅助药品的合理使用

Promoting the Rational Use of Adjuvant Drugs by Various Control and Intervention Means

目的:加强辅助药品的管控和干预,促进临床合理用药。方法:通过多种管控和干预手段的实施,评价实施前后辅助药品使用的变化。结果:综合培训、点评、反馈、约谈、奖惩、信息化管理等多种干预手段,辅助药品的使用合理率明显提升。经过管控,我院的辅助药品已基本不在全院药品销售金额排名前20名中,住院人均药品费用与住院人均辅助药品费用稳步下降,分别由2018年第一季度3511.70元和138.50元降至第四季度3344.40元和111.25元。辅助药品销售占比和医院药占比分别由2018年第一季度的2.60%和33.54%下降至第四季度2.24%和31.56%,乌司他丁冻干粉的使用合理率由干预前41.82%升高至100%,芪珍胶囊合理率由51.65%增加至100%。结论:培训、点评、反馈、约谈、奖惩、信息化管理等多种干预手段相结合能显著减少辅助药品的不合理使用,切实减轻患者的经济负担,促进临床合理用药。

Objective:To strengthen the control and intervention over adjuvant drugs and promote the clinical rational use of drugs.Methods:Various control and intervention means were implemented to evaluate changes in the use of adjuvant drugs before and after management.Results:Through various means of interventions such as training,comments,feedback,interviews,reward and punishment and informatization management,the rational use of auxiliary drugs has significantly increased.After the control,the adjuvant drugs were no longer in the top 20 drugs sold.The per capita cost of drugs and adjuvant drugs has decreased from 3511.70 and 138.50 in the first quarter of 2018 to 3344.40 and 111.25 in the fourth quarter.The proportions of adjuvant drugs and the hospital drugs sold fell from 2.60%and 33.54%in the first quarter to 2.24%and 31.56%in the fourth quarter respectively.The rational utilization rate of ulinastatin lyophilized powder has increased from 41.82%to 100%,and the rational utilization rate of Qizhen capsules has increased from 51.65%to 100%.Conclusion:The combined use of training,comment,feedback,interviews,reward and punishment,informatization management and other means of interventions could significantly reduce the irrational use of adjuvant drugs the financial burden on patients,and promote the clinical rational use of drugs.